The Battle for Affordable Drugs: Big Pharma's Confrontation with Congress

Pharmaceutical companies are opposing a new Medicare program that allows negotiation of lower drug prices, claiming it will limit patient access to medicine and hinder new cures. However, a review reveals that the 10 drugs up for negotiation are already sold at significantly lower prices in other countries. Americans are being charged up to 1,000% more for the same drugs. Despite this, drugmakers are reporting huge revenues from foreign sales. The pharmaceutical industry has filed multiple lawsuits to block the program, but their recent earnings reports suggest they will still profit immensely. The high cost of prescription drugs in the US, which is the most expensive healthcare system globally, is a major factor in poor health outcomes.